GenoLogics, an Illumina company, is looking for an experienced Quality Assurance Analyst interested in testing applications that incorporate hybrid software and hardware systems as well as full-stack web applications. GenoLogics builds modern web applications that support leading edge genetic science. From cancer research to pharmaceuticals to forensics and more – we build software that matters and is making a difference. Our bioinformatics software enables researchers, scientists, geneticists and clinicians to manage the complex workflows required to successfully sequence the genome. We do interesting and important work. This is an opportunity to work as part of talented team and develop world-class products.
Headquartered in San Diego, California, Illumina (NASDAQ: ILMN), is a leading developer, manufacturer, and marketer of next generation life science tools and integrated systems for large-scale analysis of genetic variation and biological function. These systems are enabling studies that were not even imaginable just a few years ago, and moving us closer to the realization of personalized medicine. With the innovative advances in our sequencing technologies, we are rapidly impacting the clinical market in areas such as reproductive health and oncology. The expanding Illumina oncology portfolio of next- generation sequencing NGS and microarray technologies is revolutionizing cancer genomics research. Our customers include a broad range of academic, government, pharmaceutical, biotechnology, and other leading institutions around the globe.
lllumina has experienced phenomenal growth from $10 million in revenues in 2002 to over $2.4 billion in 2016. Forbes named Illumina #1 on the 2009 list of 25 Fastest-Growing Technology Companies in the United States, the second time over a three year period that Forbes ranked Illumina #1 on its list of rapidly growing technology companies. Illumina was also named #1 smartest company in the world as part of MIT’s 2014 Technology Review. As of April 2017, the company had a $25 billion market capitalization.